Clinical Practice
Cobenfy for Schizophrenia: A 2026 PMHNP Prescribing Guide
Cobenfy is the first schizophrenia drug that skips D2 blockade entirely. Here is how PMHNPs dose, titrate, and monitor xanomeline-trospium safely in 2026.
Tagged
antipsychotic prescribing
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Clinical Practice
Early Clozapine After One Failed Antipsychotic: What PMHNPs Need to Know
A 2026 JAMA Psychiatry RCT found clozapine outperformed second-line options after one failed antipsychotic in first-episode psychosis. Here's what PMHNPs should know about early clozapine use, post-REMS monitoring, and building prescribing confidence.